Serum Institute To Launch Novavax Vaccine Shot For Children In Six Months
Adar Poonawalla said that their vaccine will be launched in six months adding that it is under trial and has shown excellent data all the way down to the age group of 3.
Adar Poonawalla said that their vaccine will be launched in six months adding that it is under trial and has shown excellent data all the way down to the age group of 3.
The clinical trials as a part of phase III clinical trials involved nearly 25,800 volunteers spanning 25 hospitals across the country.
Preliminary data suggests that while two doses of the Pfizer vaccine are 88 percent protective against symptomatic infection with the B.1.617.2 variant, a single dose is only 33 percent effective.
The Serum Institute of India is producing the Oxford/AstraZeneca two-dose vaccine as Covishield. The same is being made available among the adult population in India.
Dr Alison Astles said, “My brother was just extraordinarily unlucky. Despite what has happened to our family, we strongly believe that everyone should go for their first and second doses of the AstraZeneca vaccine.”
Norway, Denmark, Iceland and one region of Italy have all also temporarily halted their AstraZeneca immunisation programs while they investigate.
Natasha Poonawalla serves as the director of Poonawalla Science Park in the Netherlands and Villoo Poonawalla Racing and Breeding Pvt Ltd.